Acute infection — antivirals & antimicrobials
One of 5 mechanistic pathways to 🛡️ Immune resilience · 15 options
Different from prevention. These aim to shorten or blunt an infection in progress, and timing dominates efficacy — most of them only work if started within the first day or two.
The differential white count separates viral from bacterial better than how you feel does — and it decides whether anything in this pathway is even the right category.
Complete Blood Count (CBC) with Differentialhs-CRP (High-Sensitivity C-Reactive Protein)ESR (Sed Rate)Vitamin D (25-Hydroxy)🛡️ Frequent Illness & Immune Resilience covers these in one panel →
What engages this pathway
Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.
🧬 Elderberry
Anthocyanins appear to block viral hemagglutinin entry. Meta-analysis supports reduced duration of upper-respiratory symptoms when started early.
🧬 Zinc
Zinc lozenges reduce common-cold duration by roughly a third in meta-analysis — but only ionic zinc, only lozenges dissolving in the throat, and only started within 24 hours. Most products fail at least one of those conditions.
🧬 Vitamin C
Does not prevent colds in the general population; does modestly shorten them, with a larger effect in people under heavy physical stress.
🧬 L-Lysine
Competes with arginine, which herpes viruses need to replicate. Trial evidence for reduced HSV recurrence frequency.
🧬 Monolaurin
Disrupts lipid envelopes of viruses and some bacteria in vitro.
🧬 Olive Leaf Extract
Oleuropein with antiviral activity in cell models.
🧬 Andrographis
Meta-analysis supports symptom reduction in upper-respiratory infection; one of the better-evidenced botanicals here.
🧬 Echinacea
Trial results are genuinely mixed and species- and preparation-dependent. Purpurea aerial-part extracts performed best.
🧬 Propolis
Antimicrobial and antiviral bee resin with trial evidence in upper-respiratory infection and oral lesions.
🧬 Manuka Honey
Methylglyoxal-driven antibacterial activity with real wound-care evidence and cough-suppression data.
🧬 Oregano Oil
Broad-spectrum carvacrol activity; hard on commensals with prolonged use.
🧬 Cat's Claw
Immunomodulatory alkaloids with traditional use in viral illness.
🧬 Black Seed Oil
Thymoquinone with antimicrobial and anti-inflammatory trial data across several conditions.
🧬 Vitamin D
Prophylactic supplementation reduces acute respiratory infection; large bolus dosing during an infection does not appear to help.
💉 Thymosin Alpha 1
Used as an adjunct in severe viral illness in several countries; it modulates rather than suppresses.
What actually decides this outcome, in order of size
Everything on this page is a treatment rather than a prevention, which means the clock decides the outcome before the molecule does. Ranked by how much of the outcome each one owns:
- How many hours have passed since the first symptom. The trials that produced the positive results on this page enrolled people within the first day or two, and the effect of treatment on illness duration has been reanalyzed with quantile methods precisely because a mean duration hides who benefited Hemila 2022. A lozenge started on day three is not an under-dosed version of the trial. It is outside it.
- Whether the preparation is the one that was studied. For zinc this is unusually strict: the trials used lozenges dissolving slowly in the mouth, releasing ionic zinc, and the whole field has an active methodological dispute about how those trials should be pooled Hemila 2024. A capsule swallowed with water is a different intervention with the same element in it.
- Whether the question is prevention or treatment, because the answers differ by agent. Vitamin D supplementation reduces acute respiratory infection as prophylaxis in a systematic review and meta-analysis of randomized trials Jolliffe 2021. Vitamin C does not prevent colds in the general population and does shorten them, with a larger effect under heavy physical stress Hemila 2013. Those are two different verdicts on two different questions and neither transfers.
- Whether the illness is viral, bacterial or neither. Nothing on this page treats a bacterial pneumonia, and the honest role of the shelf is symptom duration in a self-limiting viral illness. A fever past a few days, breathlessness, a stiff neck, confusion or a deteriorating course is a clinician, not a cupboard.
- The products, last, and the size of the best of them is modest. Black elderberry has a meta-analysis for upper respiratory symptoms Hawkins 2019 and a broader systematic review of prevention and treatment Wieland 2021. Andrographis paniculata has a Cochrane review for symptomatic relief of acute respiratory infection Hu 2017 and an earlier systematic review of safety and efficacy Coon 2004. These are days of symptoms, not cures.
The order to run these in, and what has to be true first
Decide in advance, buy in advance, and start within hours. A shelf that only works inside the first day cannot be assembled on the second day, which is the practical reason most readers never see the effect the trials found.
- Have it in the house before the season. This is the single most useful sentence on the page and it costs nothing. The trials that worked started early Hemila 2022, and the delay between first symptom and first dose is usually a shopping delay.
- Zinc as a lozenge, dissolved slowly, starting at the first scratch. The route is the mechanism: the proposed action is local in the oropharynx as well as systemic, and it is why the format is not interchangeable. The field's own disagreement about pooling is worth knowing rather than hiding Hemila 2024.
- Vitamin C is a duration agent with a defined population. It does not prevent colds in ordinary circumstances and does shorten them, and the largest effects were under heavy physical stress Hemila 2013. Somebody training hard through a winter is the reader this actually applies to.
- Elderberry next, and read the anthocyanin question honestly. The randomized influenza trial Zakay-Rones 2004 and the meta-analysis Hawkins 2019 sit alongside a larger emergency-department randomized trial in children and adults that did not find benefit Macknin 2020. Elderberry anthocyanin bioavailability has been measured directly and is low Milbury 2002, which is a real constraint on any systemic mechanism.
- Andrographis is the botanical with the best review base and a safety file worth reading. Cochrane covers symptomatic relief Hu 2017, and a systematic review and meta-analysis covers safety Worakunphanich 2021. Hypersensitivity reactions have been examined specifically for this plant, which is more scrutiny than most of the shelf has had.
- Echinacea is genuinely unsettled and the negatives are large. Cochrane found the evidence inconsistent across preparations Karsch-Völk 2014, an experimental rhinovirus challenge study found no effect Turner 2005, and a large randomized trial found no clinically meaningful benefit Barrett 2010. Species, plant part and extraction differ between every one of those, which is the field's problem rather than an excuse.
- L-Lysine is for a different virus and its own literature disagrees. One clinical series reported success in frequently recurrent herpes simplex Griffith 1987 and another reported failure Simon 1985; a later review weighs both Mailoo 2017. The arginine-competition mechanism is coherent and the human evidence is split.
- Propolis, Manuka Honey, Black Seed Oil, Monolaurin, Olive Leaf Extract, Oregano Oil and Cat's Claw are the mechanism tier. Envelope disruption and broad-spectrum phenolic activity are demonstrated in vitro and are not the same as a clinical result. Thymosin Alpha 1 is used as an adjunct in severe viral illness in several health systems and is not a cold remedy.
What gets bought for this that cannot move it
The category fails against its own control condition: the illness ends anyway. An untreated upper respiratory infection resolves in about a week, so anything started on day three is followed by improvement no matter what it was. This is why the informative analyses are randomized and why the interesting statistical work is about the distribution of durations rather than the mean Hemila 2022. Personal experience of this shelf is almost entirely uninterpretable, in both directions.
Echinacea is the item on this page whose reputation most exceeds its evidence. A rhinovirus challenge study, in which the exposure is known and timed, found no effect Turner 2005, and the Cochrane review across preparations is inconsistent Karsch-Völk 2014. Read that as a preparation problem if you like, and then notice that the preparation you can buy is not identified by any of those trials either.
Broad-spectrum antimicrobial botanicals do not know which bacteria you meant. Carvacrol and thymol are membrane-active against a wide range of organisms, and the colon is a wide range of organisms. Using Oregano Oil for weeks to treat a week-long viral illness is a category error with a cost, and the cost lands on the microbiome that Microbiome composition & prebiotic substrate is about.
And if infections keep happening, this is the wrong page. Frequent, severe or unusually slow-resolving infections are a question about baseline immune competence and route to Innate immunity & trained immunity and to Thymic function & adaptive immunity. Recurrent sinus, gut or urinary infections route to Barrier & mucosal immunity. Prevention across a winter is a vitamin D question rather than an acute-treatment one Jolliffe 2021.
How you would know it was working, on a real read-out and a real timescale
The prediction is measurable and almost nobody measures it: if something here works, symptom duration from first symptom to last should shorten across repeated episodes, in a person who starts within hours every time. One episode proves nothing. The blood work on this page exists mostly to stop you drawing it at the wrong moment.
- Duration in days, recorded from the first symptom, across at least three episodes. Written down at the time rather than remembered afterwards, because recall of how long a cold lasted is biased by how bad the worst day was. This is the only endpoint on this page that maps onto what the trials measured Hemila 2013.
- Vitamin D (25-Hydroxy) measured when well, not during the illness. It is the prophylactic lever with randomized evidence Jolliffe 2021, and 25-hydroxyvitamin D falls as an acute-phase response, so a level drawn mid-infection reads low for a reason that has nothing to do with stores.
- Zinc, Plasma measured when well, for the same reason and more strongly. Plasma zinc drops sharply in acute inflammation because zinc is redistributed into the liver, so a low value taken during a cold is a description of the cold. Measured in health it is a genuine status marker, with the usual caveat that plasma is a poor reflection of total body zinc.
- Ferritin and hs-CRP (High-Sensitivity C-Reactive Protein) read as a pair, never alone. Ferritin is an acute-phase reactant and rises with any inflammatory stimulus, so a ferritin drawn during an infection can look reassuring in somebody who is iron deficient. If hs-CRP (High-Sensitivity C-Reactive Protein) is raised, the ferritin is not interpretable and needs repeating when well.
- Complete Blood Count (CBC) with Differential with a differential if episodes are frequent or severe. This is the point at which the question stops being which botanical and starts being whether the immune system is normal, and it is one tube.
What will fool you. The natural history is the confounder that beats everything: you take something on day three, you recover on day seven, and you would have recovered on day seven. Seasonality means the winter you started a new supplement is also a winter with a different circulating virus. A negative personal result on an echinacea product is uninformative because the trials themselves cannot agree on which preparation is being tested Karsch-Völk 2014. And elderberry anthocyanins are poorly absorbed Milbury 2002, so a systemic-mechanism story told about them is running ahead of the pharmacokinetics.
Sources read for these sections
- Hemila H. Quantile Treatment Effect of Zinc Lozenges on Common Cold Duration: A Novel Approach to Analyze the Effect of Treatment on Illness Duration. Frontiers in Pharmacology 2022;13:817522 · PMID 35177991
- Hemila H. Shortcomings in the Cochrane review on zinc for the common cold (2024). Frontiers in Medicine (Lausanne) 2024;11:1461210 · PMID 39478818
- Hemila H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews, 2013 · PMID 23440782
- Jolliffe DA. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes and Endocrinology 2021;9(5):276-292 · PMID 33798465
- Hawkins J, et al. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials. Complementary Therapies in Medicine 2019 · PMID 30670267
- Wieland LS, et al. Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review. BMC Complementary Medicine and Therapies 2021 · PMID 33827515
- Zakay-Rones Z, et al. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. Journal of International Medical Research 2004 · PMID 15080016
- Macknin M, et al. Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial. Journal of General Internal Medicine 2020 · PMID 32929634
- Hu XY, et al. Andrographis paniculata (Chuan Xin Lian) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis. PLoS One 2017 · PMID 28783743
- Coon JT, Ernst E. Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy. Planta Medica 2004 · PMID 15095142
- Worakunphanich W, et al. Safety of Andrographis paniculata: A systematic review and meta-analysis. Pharmacoepidemiology and Drug Safety 2021 · PMID 33372366
- Karsch-Völk M. Echinacea for preventing and treating the common cold. Cochrane Database of Systematic Reviews 2014 · PMID 24554461
- Turner RB. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. New England Journal of Medicine 2005 · PMID 16049208
- Barrett B. Echinacea for treating the common cold: a randomized trial. Annals of Internal Medicine 2010 · PMID 21173411
- Griffith RS. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Dermatologica 1987 · PMID 3115841
- Simon CA. Failure of lysine in frequently recurrent herpes simplex infection. Archives of Dermatology 1985 · PMID 3919651
- Mailoo VJ. Lysine for Herpes Simplex Prophylaxis: A Review of the Evidence. Integrative Medicine (Encinitas) 2017 · PMID 30881246
- Milbury PE, et al. Bioavailablility of elderberry anthocyanins. Mechanisms of Ageing and Development 2002 · PMID 12044949
The other 4 routes to immune resilience
Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.
You know the goal. Skool has the plan.
This pathway is one arm of The Immune resilience Blueprint. The members' version has where this arm sits in the sequence, what to stack it with, and the markers that tell you to keep going or stop.
Open The Immune resilience Blueprint in Skool →$10/mo, cancel anytime.
← Open this pathway in the interactive Vault
Frequently asked questions
Different from prevention. These aim to shorten or blunt an infection in progress, and timing dominates efficacy — most of them only work if started within the first day or two.
15 options are mapped to this pathway in the Vault, including Elderberry, Zinc, Vitamin C, L-Lysine. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 11 carry clinical validation and 4 are mechanistic predictions.
The differential white count separates viral from bacterial better than how you feel does — and it decides whether anything in this pathway is even the right category. The markers worth checking are Complete Blood Count (CBC) with Differential, hs-CRP (High-Sensitivity C-Reactive Protein), ESR (Sed Rate), Vitamin D (25-Hydroxy).
Unproven is not the same as ineffective. Of the 15 options on this pathway, 11 have clinical validation and 4 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.
Where this goes next
Everything above is the free case for Acute infection — antivirals & antimicrobials. The protocol — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.